2019 | Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2020 | Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma | STRAHLENTHERAPIE UND ONKOLOGIE |
2019 | Dose perturbation by metallic biliary stent in external beam radiotherapy of pancreato-biliary cancers | AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE |
2009 | Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect | GENE THERAPY |
2018 | Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus | ANNALS OF SURGICAL ONCOLOGY |
2022 | Early experience of combining immune checkpoint inhibitor and radiotherapy in heavily pretreated hepatobiliary cancer | JOURNAL OF CLINICAL ONCOLOGY |
2012 | Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2011 | Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2011 | Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study.
| CANCER RESEARCH AND TREATMENT |
2014 | Effective Biliary Drainage and Proper Treatment Improve Outcomes of Hepatocellular Carcinoma with Obstructive Jaundice
| GUT AND LIVER |
2020 | Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2021 | Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer
| RADIATION ONCOLOGY |
2007 | Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2013 | Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2014 | Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanced pancreatic cancer | CHEMOTHERAPY |
2011 | Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2013 | Gastrointestinal hemorrhage after concurrent chemoradiotherapy in locally advanced pancreatic cancer
| GUT AND LIVER |
2013 | Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer | PANCREATOLOGY |
2014 | Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma. | JOURNAL OF NEURO-ONCOLOGY |
2012 | High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2008 | Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: A case report
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2010 | Identification of proteins indicating radiation-induced hepatic toxicity in cirrhotic rats
| JOURNAL OF RADIATION RESEARCH |
2014 | Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2006 | Intermediate Dose 5-Fluorouracil-Induced Encephalopathy
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
2013 | Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
| PLOS ONE |
2010 | Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas? | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2020 | Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria | RADIOTHERAPY AND ONCOLOGY |
2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
2022 | Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombus | JOURNAL OF CLINICAL ONCOLOGY |
2016 | Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
| YONSEI MEDICAL JOURNAL |
2005 | Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2019 | Noninvasive Biomarker for Predicting Treatment Response to Concurrent Chemoradiotherapy in Patients with Hepatocellular Carcinoma
| Investigative Magnetic Resonance Imaging |
2006 | Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Curative Resection With Tumor-Specific Mesorectal Excision for Fixed Locally Advanced Rectal Cancer: Impact of Postirradiated Pathologic Downstaging on Local Recurrence and Survival | ANNALS OF SURGERY |
2013 | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
| ONCOTARGETS AND THERAPY |
2014 | Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy
| JOURNAL OF RADIATION RESEARCH |
2012 | Pancreatoduodenectomy following neoadjuvant chemoradiation therapy in uncinate process pancreatic cancer. | PANCREAS |
2015 | Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
| MEDICINE |
2009 | Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy | RADIOLOGY |
2016 | Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
| ONCOTARGET |
2019 | Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma | DIGESTIVE AND LIVER DISEASE |
2009 | Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
2009 | Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection | LANGENBECKS ARCHIVES OF SURGERY |
2007 | Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma | HEPATOLOGY RESEARCH |
2016 | Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2009 | Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2019 | Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2016 | Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer.
| PLOS ONE |
2017 | Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and 18F-fluoro-2-deoxyglucose positron emission tomography | LIVER INTERNATIONAL |
2024 | Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy
| CANCER RESEARCH AND TREATMENT |
2011 | Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
1998 | Sensory and motor dysfunction assessed by anorectal manometry in uterine cervical carcinoma patients with radiation-induced late rectal complication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2014 | Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy | ANNALS OF SURGICAL ONCOLOGY |
2016 | The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma
| ONCOTARGET |
2009 | The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2010 | The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
| RADIATION ONCOLOGY |
2015 | The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
| MEDICINE |
1994 | The role of radiation treatment in management of extrahepatic biliary tract metastasis from gastric carcinoma | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2012 | The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma. | LIVER INTERNATIONAL |